Mammalian imidazoline receptor

You’ve invested time, talent, and energy into making a dent in the universe with your invention and ideas. Now it’s time to make sure it’s protected with a PowerPatent Utility, Provisional or Design Patent Application

The Incyte Genomics, Inc. patent solves the following problem:

Phylogenetic relationships among organisms shown many times, and studies from a diversity of prokaryotic and eukaryotic organisms suggest a more or less gradual evolution in biochemical and physiological mechanisms and metabolic pathways . Despite the different evolutionary pressures, the proteins that control the cell cycle in yeast, nematode, flies, mice, and humans have common chemical and structural parts and modulate the same general movement. Comparing human gene sequences from other organisms which structure and / or function known allow researchers to draw analogies, and developing model systems for testing diagnostic and therapeutic agents for the human condition, diseases, and disorders.

Our analysis of this patent is as follows:

Incyte Genomics, Inc.’s patent US 6475752 B1 deals with Mammalian imidazoline receptor.
The present invention is a mammal nucleic acid molecules and fragments thereof. It also provides for the use of mammal nucleic acid molecules for the characterization, diagnosis, evaluation, treatment, or prevention of conditions, diseases and disorders associated with the expression and production for a model system. the invention further provides expression vector and host cells for production of proteins encoded in the mammalian nucleic acid molecule. the invention further provides a mammal proteins or portions thereof. the invention further provides for the use of nucleic acid molecules and proteins in assays to detect or purify ligands.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.